500 Burrard Street
Vancouver, BC V6C 2B5
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees:
|Dr. Alvaro Francisco Torres||Co-Founder, CEO & Director||210.24k||N/A||1979|
|Mr. Swapan Kakumanu ACA, ACWA, CGA||CFO & Corp. Sec.||46.21k||N/A||1970|
|Ms. Franziska Katterbach||Pres of Khiron Europe||297.05k||N/A||N/A|
|Mr. Manuel Buendia||VP of Operations||N/A||N/A||N/A|
|Mr. Luis Chavez||Country Mang. of Mexico||N/A||N/A||N/A|
|Mr. Marco Algorta||Country Mang. of Uruguay||N/A||N/A||N/A|
|Mr. Juan Diego Alvarez||VP of Regulations||N/A||N/A||1985|
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.